Overview

Influenza Vaccine Market is projected to value over USD 7 billion by 2027 end with a CAGR of over 6.2% during the forecast period 2020 to 2027.

The rise in the number of initiatives undertaken by government authorities for creating awareness regarding influenza, advancements in the medications provided for influenza treatment thus minimizing the side effects associated with influenza are some of the factors accountable for the proliferation of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Influenza Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Influenza Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Influenza Vaccine Market:

• ASTRAZENECA PLC (ASTRAZENECA)
• BIODIEM
• CSL LIMITED (SEQIRUS GMBH)
• EMERGENT BIOSOLUTIONS
• F. HOFFMANN-LA ROCHE LTD.
• GAMMA VACCINES PTY LTD.
• GLAXOSMITHKLINE PLC
• MERCK & CO., INC. (MERCK SHARP & DOHME CORP.)
• NOVARTIS AG
• PFIZER INC.
• SANOFI
• SINOVAC BIOTECH LTD.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Influenza Vaccine Market Segmentation:

By Vaccine Type

• Quadrivalent
• Trivalent

By Type

• Seasonal
• Pandemic

By Technology

• Egg-based
• Cell-based

By Age Group

• Pediatric
• Adult

By Route of Administration

• Injection
• Nasal Spray

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Influenza Vaccine Market By Vaccine Type, By Type, By Technology, By Age Group, By Route of Administration and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 

 2.  Research Methodology 
      2.1 Research Data 
         2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
         2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
      2.2 Market Size Estimation 
      2.3 Market Breakdown and Data Triangulation 
      2.4 Assumptions for the Study  

3. Executive Summary
       3.1 Market Outlook
       3.2 Segment Outlook
       3.3 Competitive Insights

4. Global Influenza Vaccine Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Market Overview
       5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Influenza Vaccine Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Influenza Vaccine Market Analysis Tools
       6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
       6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
       6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
       6.4. Market Entry Strategies
       6.5. Case Studies

7. Global Influenza Vaccine Market, By Vaccine Type Historical Analysis and Forecast 2020-2027 (USD Million)
       7.1. Quadrivalent
       7.2. Trivalent

8. Global Influenza Vaccine Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million)
       8.1. Seasonal
       8.2. Pandemic 

9. Global Influenza Vaccine Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
       9.1. Egg-based
       9.2. Cell-based

10. Global Influenza Vaccine Market, By Age Group Historical Analysis and Forecast 2020-2027 (USD Million)
       10.1. Pediatric
       10.2. Adult 

11. Global Influenza Vaccine Market, By Route of Administration Historical Analysis and Forecast 2020-2027 (USD Million)
       11.1. Injection
       11.2. Nasal Spray

12.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       12.1. Introduction
       12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            12.2.1. U.S.A
            12.2.2. Canada
            12.2.3. Mexico
       12.3. Market Size (USD Million) Forecast for North America 2020-2027

13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       13.1. Introduction
       13.2. Regional Market Trends
       13.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            13.3.1. Brazil
            13.3.2. Venezuela
            13.3.3. Argentina
            13.3.4. Rest of Latin America
       13.4. Market Size (USD Million) Forecast for Latin America 2020-2027

14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       14.1. Introduction
       14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            14.2.1. Germany
            14.2.2. U.K
            14.2.3. France
            14.2.4. Italy
            14.2.5. Spain
            14.2.6. Russia
            14.2.7. Poland
            14.2.8. Switzerland
            14.2.9. Rest of Western Europe

15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       15.1. Introduction
       15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             15.2.1. Japan
             15.2.2. China
             15.2.3. Singapore
             15.2.4. India
             15.2.5. Australia and New Zealand
             15.2.6. ASEAN
             15.2.7. South Korea
             15.2.8. Rest of Asia Pacific
       15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027

16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       16.1. Introduction
       16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             16.2.1. Saudi Arabia
             16.2.2. UAE
             16.2.3. South Africa
             16.2.4. Egypt
       16.3. Market Size (USD Million) Forecast for MEA 2020-2027

17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
       17.1. ASTRAZENECA PLC (ASTRAZENECA)
                17.1.1. Company Overview
                17.1.2. Product Portfolio
                17.1.3. SWOT Analysis
                17.1.4. Financial Overview
                17.1.5. Strategic Overview
       17.2. BIODIEM
                17.2.1. Company Overview
                17.2.2. Product Portfolio
                17.2.3. SWOT Analysis
                17.2.4. Financial Overview
                17.2.5. Strategic Overview
       17.3. CSL LIMITED (SEQIRUS GMBH)
                17.3.1. Company Overview
                17.3.2. Product Portfolio
                17.3.3. SWOT Analysis
                17.3.4. Financial Overview
                17.3.5. Strategic Overview
       17.4. EMERGENT BIOSOLUTIONS
                17.4.1. Company Overview
                17.4.2. Product Portfolio
                17.4.3. SWOT Analysis
                17.4.4. Financial Overview
                17.4.5. Strategic Overview
       17.5. F. HOFFMANN-LA ROCHE LTD.
                17.5.1. Company Overview
                17.5.2. Product Portfolio
                17.5.3. SWOT Analysis
                17.5.4. Financial Overview
                17.5.5. Strategic Overview
       17.6. GAMMA VACCINES PTY LTD.
                17.6.1. Company Overview
                17.6.2. Product Portfolio
                17.6.3. SWOT Analysis
                17.6.4. Financial Overview
                17.6.5. Strategic Overview
       17.7. GLAXOSMITHKLINE PLC
                17.7.1. Company Overview
                17.7.2. Product Portfolio
                17.7.3. SWOT Analysis
                17.7.4. Financial Overview
                17.7.5. Strategic Overview
       17.8. MERCK & CO. INC. (MERCK SHARP & DOHME CORP.)
                17.8.1. Company Overview
                17.8.2. Product Portfolio
                17.8.3. SWOT Analysis
                17.8.4. Financial Overview
                17.8.5. Strategic Overview
       17.9. NOVARTIS AG
                17.9.1. Company Overview
                17.9.2. Product Portfolio
                17.9.3. SWOT Analysis
                17.9.4. Financial Overview
                17.9.5. Strategic Overview
       17.10. PFIZER INC.
                17.10.1. Company Overview
                17.10.2. Product Portfolio
                17.10.3. SWOT Analysis
                17.10.4. Financial Overview
                17.10.5. Strategic Overview
       17.11. SANOFI
                17.11.1. Company Overview
                17.11.2. Product Portfolio
                17.11.3. SWOT Analysis
                17.11.4. Financial Overview
                17.11.5. Strategic Overview
       17.12. SINOVAC BIOTECH LTD.
                17.12.1. Company Overview
                17.12.2. Product Portfolio
                17.12.3. SWOT Analysis
                17.12.4. Financial Overview
                17.12.5. Strategic Overview

18. FutureWise SME key takeaway points for Client

Tables

Figures